Pfizer Oncology launched this week a technology innovation challenge, Advancing Care for Patients Living with mBC. This is a first-of-its-kind initiative being launched by the global breast cancer team that will award $250K in prize funding to new and relevant technology-enabled solutions that help support and empower patients with metastatic breast cancer (mBC) around the world.
Specifically, Pfizer is calling on organizations, developers, entrepreneurs, designers and innovators globally to develop technology solutions that offer patients:
- An intuitive, customizable and tailored care management solution that improves care and disease management for patients living with mBC, incorporating a comprehensive approach to well-being across the care continuum
- Solutions to support mBC patients with their daily living and enrich their lives
- Solutions to help patients living with mBC engage and support one another.
Deadline: December 2, 2016